Dermatitis  >>  Eucrisa (crisaborole)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Eucrisa (crisaborole) / Pfizer
NCT04008784: Improvement of Short Term Outcome of Mild to Moderate Atopic Dermatitis Using a Combination of Crisaborole and a Concomitant Topical Corticosteroid Over a 8 Week Period

Completed
N/A
16
US
Crisaborole 2% Topical Application Ointment [EUCRISA], Triamcinolone Acetonide 0.1% Ointment
Clinical Research Center of the Carolinas, Pfizer
Atopic Dermatitis
07/20
09/20
NCT03770858: Wearable Skin Sensors to Assess Nocturnal Scratch Behavior

Completed
N/A
23
US
Crisaborole, Scratch sensor
Northwestern University, Pfizer
Atopic Dermatitis
08/21
08/22

Download Options